Exploring Privileged Structure Repurposing: Target Similarity as a Catalyst for Cross-Species Drug Discovery.
Three core medicinal chemistry strategies, including side-chain replacement, conformational constraint, and scaffold hopping, are applied to optimize the lead compound and validate this strategy through representative case studies and summarize key practical challenges: off-target toxicity and difficulties in modifying privileged scaffolds.